» Authors » Miia Valkonen

Miia Valkonen

Explore the profile of Miia Valkonen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 460
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Inkinen N, Selander T, Pettila V, Valkonen M, Backlund M, Wennervirta J, et al.
Acta Anaesthesiol Scand . 2020 Apr; 64(8):1210-1217. PMID: 32270496
Background: Oliguria is a frequent trigger for administering a fluid bolus, but the effect of fluid bolus in improving urine output is inadequately demonstrated. Here, we summarize the protocol and...
12.
Ala-Houhala M, Valkonen M, Kolho E, Friberg N, Anttila V
Infect Dis (Lond) . 2019 Sep; 51(11-12):824-830. PMID: 31507238
Candidemia is a life-threatening infection with high mortality. Our aim was to evaluate the species distribution, antifungal susceptibilities and risk factors associated with 30-day mortality in candidemia in Southern Finland....
13.
Martin-Loeches I, Lemiale V, Geoghegan P, McMahon M, Pickkers P, Soares M, et al.
Crit Care . 2019 May; 23(1):152. PMID: 31046842
Background: It is unclear whether influenza infection and associated co-infection are associated with patient-important outcomes in critically ill immunocompromised patients with acute respiratory failure. Methods: Preplanned secondary analysis of EFRAIM,...
14.
Ianevski A, Zusinaite E, Shtaida N, Kallio-Kokko H, Valkonen M, Kantele A, et al.
Viruses . 2019 Mar; 11(3). PMID: 30832226
With the increasing pace of global warming, it is important to understand the role of meteorological factors in influenza virus (IV) epidemics. In this study, we investigated the impact of...
15.
Lindstrom M, Valkonen M, Tohmola N, Renkonen R, Strandin T, Vaheri A, et al.
Clin Chim Acta . 2019 Feb; 493:20-24. PMID: 30802439
Background: Bradykinin is an important mediator of inflammation and vascular permeability and could have an important role in the development of septic shock. Measurement of bradykinin by immunological methods may...
16.
Jakkula P, Pettila V, Skrifvars M, Hastbacka J, Loisa P, Tiainen M, et al.
Intensive Care Med . 2018 Nov; 44(12):2091-2101. PMID: 30443729
Purpose: We aimed to determine the feasibility of targeting low-normal or high-normal mean arterial pressure (MAP) after out-of-hospital cardiac arrest (OHCA) and its effect on markers of neurological injury. Methods:...
17.
Pickkers P, Mehta R, Murray P, Joannidis M, Molitoris B, Kellum J, et al.
JAMA . 2018 Oct; 320(19):1998-2009. PMID: 30357272
Importance: Sepsis-associated acute kidney injury (AKI) adversely affects long-term kidney outcomes and survival. Administration of the detoxifying enzyme alkaline phosphatase may improve kidney function and survival. Objective: To determine the...
18.
Ianevski A, Zusinaite E, Kuivanen S, Strand M, Lysvand H, Teppor M, et al.
Antiviral Res . 2018 Apr; 154:174-182. PMID: 29698664
According to the WHO, there is an urgent need for better control of viral diseases. Re-positioning existing safe-in-human antiviral agents from one viral disease to another could play a pivotal...
19.
Azoulay E, Pickkers P, Soares M, Perner A, Rello J, Bauer P, et al.
Intensive Care Med . 2017 Sep; 43(12):1808-1819. PMID: 28948369
Background: In immunocompromised patients with acute hypoxemic respiratory failure (ARF), initial management aims primarily to avoid invasive mechanical ventilation (IMV). Methods: To assess the impact of initial management on IMV...
20.
Vahtera A, Valkonen M, Huhtala H, Pettila V, Kuitunen A
Thromb Res . 2017 Aug; 158:71-75. PMID: 28846877
Introduction: In intensive care unit (ICU) patients, subcutaneous low-molecular weight heparin thromboprophylaxis results in lower plasma anti-factor Xa (anti-FXa) levels compared to general ward patients. The aim of this study...